Skip to main contentSkip to navigationSkip to search
07.06.15, 9:22| Regulatory information

Trade subject to notification - Medicult

This represents 9.77 % of the share capital.
 
 
 
Ref.:
Rune Helland, SVP Investor Relations, Tel: +47 2254 4411
 

Attachments